Beam Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Beam Therapeutics exhibits at Booth 2628 at ASH 2026 in New Orleans. Beam Therapeutics supports a symposium on the fast-changing treatment of sickle cell disease. Framed as a guide for hematologists, it covers gene-based therapies, activators and other new approaches.
| Organization | ASH 2026 Attendance |
|---|---|
Beam Therapeutics Cambridge, MA | |
Biotechnology company developing precision genetic medicines with base editing, including therapies for sickle cell disease. | Booth Exhibiting at Booth 2628 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00am–10:00am A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them. |
Find decision makers at Beam Therapeutics
Tell us what you sell and we’ll find the people at Beam Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction